Quantcast

Latest brain cancer Stories

2014-08-13 08:29:58

Phase III Trial Is Alive And Well; "Hint Of Failure" A Complete Fabrication; No Interim Analysis of Efficacy Done; 55 Patients' Positive Data Independently Collected. BETHESDA, Md., Aug. 13, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today corrected ongoing false claims by Adam Feuerstein published on the TheStreet.com about the Company's Phase III trial of DCVax-L...

2014-08-11 08:29:18

Trial Progressing On Track; BETHESDA, Md., Aug. 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced an update about the Company's Phase III clinical trial of DCVax®-L for Glioblastoma multiforme (GBM) brain cancer in conjunction with the Company's separate announcement today about certain changes to the Phase III trial. The update from the Company...

2014-08-11 08:29:14

Important New Variable Covered. Threshold for Meeting Primary Endpoint Lowered. BETHESDA, Md., Aug. 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that, following a 9-month process of regulatory submissions and reviews by regulators in the US, UK and Germany, it has obtained regulatory approvals to make certain enhancements to its ongoing...

2014-07-31 23:07:34

Researchmoz, provider of premium market research report announces the addition of "Brain Cancer - Pipeline Review, H2 2014" to its store. Albany, NY (PRWEB) July 31, 2014 Global Markets , Brain Cancer - Pipeline Review, H2 2014, provides an overview of the Brain Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Brain Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target,...

2014-07-24 16:24:49

Tony Danza Appointed as Master of Ceremonies for the Charitable Event NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- Voices Against Brain Cancer, in partnership with New York Road Runners, will host its annual "Join The Voices! New York Run/Walk" on Sunday, August 10, 2014 at The Naumburg Bandshell in Central Park at 8:30 a.m. The charitable event, which last year raised close to one million dollars, will feature a five-mile run, a scenic walk, kids races and a fun family festival....

2014-07-16 12:42:09

University of North Carolina Health Care UNC researchers lay the groundwork for a new approach to brain cancer treatments and a better understanding of Parkinson's disease Researchers at the UNC School of Medicine have discovered that the protein PARC/CUL9 helps neurons and brain cancer cells override the biochemical mechanisms that lead to cell death in most other cells. In neurons, long-term survival allows for proper brain function as we age. In brain cancer cells, though, long-term...

2014-06-22 23:03:27

Dr. Leroy Hood, Institute for Systems Biology President, Accepts CEF’s Annual Inspirational Award on Dr. Foltz’ Behalf Seattle, WA (PRWEB) June 22, 2014 Dr. Greg Foltz, longtime supporter of the Chris Elliott Fund, and eminent Seattle neurosurgeon and researcher, was this year’s recipient of CEF’s Inspirational Award, presented annually at the Brains Matter Awareness and Celebration Luncheon. As a young man, Dr. Foltz gave up a promising career as a pianist to pursue a career as a...

2014-05-08 12:29:01

#TuneIn2GBM Social Media Campaign to Raise Awareness to Help Fight a Deadly Form of Brain Cancer PORTSMOUTH, N.H., May 8, 2014 /PRNewswire/ -- For the second consecutive year, Novocure is sponsoring its Tune-In to GBM campaign, a public call to action to "Tune-In" to glioblastoma (GBM) during National Brain Cancer Awareness Month this May. After the success of last year's inaugural campaign, Novocure is excited to combine forces with the Cancer Support Community, the Chris Elliott...

2014-04-24 12:29:32

Non-profit Announces National Call to Action for Individuals Touched By Brain Cancer NEW YORK, April 24, 2014 /PRNewswire-iReach/ -- Voices Against Brain Cancer (VABC), has declared May 9(th) as National Gray Day, in support of brain cancer awareness. Following the 2013 passing of the Louisiana Legislature by the House Concurrent Resolution 38, establishing May 9(th) as Louisiana Gray Day, VABC is lending its voice to further raise recognition for Gray Day by creating a national call to...

2014-04-22 12:30:39

Illinois Residents and Members of the Medical Community to be Honored CHICAGO, April 22, 2014 /PRNewswire-iReach/ -- Voices Against Brain Cancer will host its second annual "Join the Voices! Chicago Run/Walk" on Sunday, May 4, 2014 in Diversey Harbor, Lincoln Park. Registration begins at 8:00 AM with a 9:00 AM start time. The charitable event will feature a 5K run, a scenic walk, kids races and a fun family festival. Illinois residents, Tammy Maganini and Melissa Marotti, are this year's...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related